Evidence map›Paper›PMID 33396590›Full record

ArticleMolecules (Basel, Switzerland)2020

Antimicrobial Potential of Biosynthesized Silver Nanoparticles by

Fatimah Al-Otibi, Reem A Al-Ahaidib, Raedah I Alharbi, Rana M Al-Otaibi, Gadah Albasher

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Bioactivity-Guided Isolation of Flavone Glycoside fromMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Frontiers in chemistry · 2024
    Article
  6. Article
  7. Silver Nanoparticles ofPlants (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Synthesis of silver nanoparticles employingBiochemistry and biophysics reports · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Materials (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Antimicrobial Properties ofPharmaceutics · 2021
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatimah Al-OtibiDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Reem A Al-AhaidibDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Raedah I AlharbiDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Rana M Al-OtaibiDepartment of Botany and Microbiology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.
Gadah AlbasherDepartment of Zoology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia.

Funding

Deanship of Scientific Research, King Saud University RG-1441-357
6 · The paper itself

Abstract

The green biosynthesis of nanoparticles by plant extracts is an attractive and promising technique for medicinal applications. In the current study, we chose one of the daisy plants,

Indexed as

Microbial Sensitivity TestsNanoparticlesAntifungal AgentsAnti-Infective AgentsBacillus subtilisDiffusionEscherichia coliFusariumGas Chromatography-Mass SpectrometryHumansIonsMetal NanoparticlesMicroscopy, Electron, ScanningNanomedicinePlant ExtractsPseudomonas aeruginosaAntifungal AgentsAnti-Infective AgentsIonsPlant ExtractsSilverAaronsohnia factorovskyiantibacterialantifungalethanolic extractFT-IRsilver nanoparticlesZeta potential

Identifiers

PMID33396590
PMCPMC7795506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.